Evidence map›Paper›PMID 40666336›Full record

ArticlemedRxiv : the preprint server for health sciences2025

A Novel

Tolulope Kayode, David Niyukuri, Aurel Holzschuh, Gustavo Da Silva, Tiffany Huwe, Anita Lerch, Joseph Nyandwi, Cristian Koepfli

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tolulope KayodeEck Institute for Global Health and Department of Biological Sciences, University of Notre Dame, Indiana, United States of America.
David NiyukuriDoctoral School, University of Burundi, Bujumbura, Burundi.ORCID 0000-0002-2112-4999
Aurel HolzschuhSwiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID 0000-0002-2681-1114
Gustavo Da SilvaEck Institute for Global Health and Department of Biological Sciences, University of Notre Dame, Indiana, United States of America.ORCID 0000-0001-5248-6813
Tiffany HuweEck Institute for Global Health and Department of Biological Sciences, University of Notre Dame, Indiana, United States of America.ORCID 0000-0001-8027-8376
Anita LerchEck Institute for Global Health and Department of Biological Sciences, University of Notre Dame, Indiana, United States of America.ORCID 0000-0003-3062-5901
Joseph NyandwiDoctoral School, University of Burundi, Bujumbura, Burundi.ORCID 0000-0002-3715-7891
Cristian KoepfliEck Institute for Global Health and Department of Biological Sciences, University of Notre Dame, Indiana, United States of America.ORCID 0000-0002-9354-0414

Funding

Indiana Clinical and Translational Sciences InstituteUM1TR004402 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI Sharon M Moe, Sarah Elizabeth Wiehe · 2023 to 2026
$21.6M
Gates Foundation INV-005898NCATS NIH HHS UM1 TR004402
6 · The paper itself

Abstract

Antimalarial resistance, including failure of artemisinin combination therapy, is increasing in Africa. Molecular surveillance of markers of drug resistance is essential to monitoring drug resistance.

Indexed as

Antimalarial resistanceBurundiKelch13Molecular surveillancePlasmodium falciparumSulfadoxine-Pyrimethamine resistance

Identifiers

PMID40666336
PMCPMC12262749

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.